• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • AI Mission Austria
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol–South Tyrol–Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

The triad of blood, deep lymphatics and CSF in MS

The triad of blood, deep lymphatics and CSF in MS

Tobias Zrzavy (ORCID: 0000-0001-8909-1591)
  • Grant DOI 10.55776/J4524
  • Funding program Erwin Schrödinger
  • Status ended
  • Start October 1, 2021
  • End September 30, 2022
  • Funding amount € 43,300
  • Project website

Disciplines

Medical-Theoretical Sciences, Pharmacy (100%)

Keywords

    Multiple Sclerosis, Deep Lymphatics, Cerebrospinal Fluid, Immunophenotyping

Abstract Final report

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting brain and spinal cord. Although the underlying cause of MS is not yet known, it is well reported that immune cells of the so-called T and B propagate inflammation and pathogenesis in MS. The T and B cells of MS patients behave differently compared to healthy people, e.g. they produce other kinds proteins and react differently to stimuli. Usually, studies focus only on immune cells in the blood and the fluid around brain and spinal cord (CSF). However, in order to identify new disease-implicated immune cell subtypes a third, until now totally neglected, compartment is the lymphatic system. It composes of specialized vessels, which are used by immune cells to move throughout the body and to get activated. As part of the lymphatics, the thoracic duct is particularly interesting in MS research since it contains large amounts of immune cells that directly travel from the brain; including all kinds of disease-implicated cell subsets. Therefore, we believe that is of utmost importance to study this so far neglected compartment in MS patients as well and to assess the relationship between blood, CSF and lymphatics in order to refine MS-specific immune functions. The main goal of this project is to find new disease-implicated immune cell subtypes by studying, besides the blood and CSF, the lymphatic system. The thoracic duct drains half of the brains egressing immune cells as well as the gut-associated lymph tissue. As it is recognized that immune cells can traffic between the blood and the CNS using the lymphoid tissue as well as the gut:brain axis is increasingly being considered important we expected to exhibit a higher concentration of MS disease-relevant immune cell subsets. This approach has not been done in MS research before. We will also study the distribution of the different immune cell subtypes between the different compartments (blood, CSF, lymphatics) in order to investigate their movement patterns. We will involve 20 untreated MS patients and 10 healthy controls. Immune cells will be isolated from the blood, cerebrospinal fluid and thoracic duct lymph. After immune cell isolation, we will study disease-implicated immune cell subtypes via single-cell RNA sequencing, which allows us to assess the gene expression profile of each individual immune cell. Subsequently, we will validate our findings as well as test for previously described cell subtypes via multi-color flow cytometry which allows us to tag certain immune cells and quantify them. This project will expand the knowledge on immune cell subtypes implicated in MS pathophysiology and their distribution between anatomically distinct yet interconnected compartments (blood, CSF and lymphatics). The potentially identified cell subtypes could eventually contribute to the development of new therapeutic strategies and help to increase our understanding of MS pathophysiology.

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting brain and spinal cord. Although the underlying cause of MS is not yet known, it is well reported that immune cells of the so-called T and B propagate inflammation and pathogenesis in MS. The T and B cells of MS patients behave differently compared to healthy people, e.g. they produce other kinds proteins and react differently to stimuli. Usually, studies focus only on immune cells in the blood and the fluid around brain and spinal cord (CSF). However, in order to identify new disease-implicated immune cell subtypes a third, until now totally neglected, compartment is the lymphatic system. It composes of specialized vessels, which are used by immune cells to move throughout the body and to get activated. As part of the lymphatics, the thoracic duct is particularly interesting in MS research since it contains large amounts of immune cells that directly travel from the brain; including all kinds of disease-implicated cell subsets. Therefore, we believe that is of utmost importance to study this so far neglected compartment in MS patients as well and to assess the relationship between blood, CSF and lymphatics in order to refine MS-specific immune functions. The main goal of this project is to find new disease-implicated immune cell subtypes by studying, besides the blood and CSF, the lymphatic system. The thoracic duct drains half of the brain's egressing immune cells as well as the gut-associated lymph tissue. As it is recognized that immune cells can traffic between the blood and the CNS using the lymphoid tissue as well as the gut:brain axis is increasingly being considered important we expected to exhibit a higher concentration of MS disease-relevant immune cell subsets. This approach has not been done in MS research before. We will also study the distribution of the different cell subtypes between the different compartments (blood, CSF, lymphatics) to investigate their movement patterns. We will involve 20 untreated MS patients and 10 healthy controls. Immune cells will be isolated from the blood, cerebrospinal fluid and thoracic duct lymph. We will study disease-implicated immune cell subtypes via single-cell RNA sequencing, which allows us to assess the gene expression profile of each individual immune cell. Subsequently, we will validate our findings as well as test for previously described cell subtypes via multi-color flow cytometry which allows us to tag certain immune cells and quantify them. This project will expand the knowledge on immune cell subtypes implicated in MS pathophysiology and their distribution between anatomically distinct yet interconnected compartments (blood, CSF and lymphatics). The potentially identified cell subtypes could eventually contribute to the development of new therapeutic strategies and help to increase our understanding of MS pathophysiology.

Research institution(s)
  • University of Pennsylvania - 100%

Research Output

  • 4 Citations
  • 1 Publications
Publications
  • 2022
    Title Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials
    DOI 10.1016/j.jim.2022.113344
    Type Journal Article
    Author Mexhitaj I
    Journal Journal of Immunological Methods
    Pages 113344
    Link Publication

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • Acknowledgements
  • IFG-Form
  • Social Media Directory
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF